Thailand starts Covid vaccine drive using jabs made by king’s firm
Country aims to vaccinate 70% of people this year but experts express doubts amid supply concerns
Thailand has started its Covid vaccination campaign amid concerns over the supply of doses, which are mainly being produced locally by a royal-owned company that has no prior experience of making vaccines.
Thailand aims to vaccinate 70% of the population before the end of the year, and is relying primarily on AstraZeneca doses produced by Siam Bioscience, a company owned by King Maha Vajiralongkorn. The company is also due to supply vaccines to eight other countries in the region.